Cytori Therapeutics Inc (CYTX) Stock Analyst Ratings
NASDAQ:CYTX - Nasdaq -
ChartMill assigns a Buy % Consensus number of 60% to CYTX. The Buy consensus is the weighted average rating of the current analysts ratings.
CYTX was analyzed by 1 analysts. The buy percentage consensus is at 60. So analysts seem to be rather neutral about CYTX.
In the previous month the buy percentage consensus was at a similar level.
Only 1 analysts analyzed CYTX. So this is just the average opinion of a couple of analysts.